Abraham Ceesay

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
7 years
Director since
2023

7 years of board service in total across 3 boards, counting each seat separately. Longest: Pacira BioSciences Inc., 3 years.

3 years · Since 2023
Rapport Therapeutics Inc. Director · Chief Executive Officer
2 years · Since 2024
1 year · Since 2025

Chief executive roles

Rapport Therapeutics Inc. · Chief Executive Officer
Since June 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 21, 2026 Rapport Therapeutics Inc. Open-market sale −2,210 $29.16 $64,448
Oct 7, 2026 Rapport Therapeutics Inc. Open-market sale −1,147 $30.66 $35,167
Oct 6, 2026 Rapport Therapeutics Inc. Open-market sale −3,375 $32.03 $108,106
Sep 23, 2026 Rapport Therapeutics Inc. Open-market sale −1,952 $39.05 $76,226
Sep 23, 2026 Rapport Therapeutics Inc. Open-market sale −215 $39.86 $8,570
Sep 23, 2026 Rapport Therapeutics Inc. Open-market sale −43 $41.05 $1,765
Sep 8, 2026 Rapport Therapeutics Inc. Open-market sale −7,141 $45.56 $325,344
Sep 8, 2026 Rapport Therapeutics Inc. Open-market sale −1,069 $46.01 $49,185
Aug 25, 2026 Rapport Therapeutics Inc. Open-market sale −18,921 $49.57 $937,914
Aug 11, 2026 Rapport Therapeutics Inc. Open-market sale −3,664 $46.90 $171,842
Aug 11, 2026 Rapport Therapeutics Inc. Open-market sale −19,500 $48.04 $936,780
Aug 11, 2026 Rapport Therapeutics Inc. Open-market sale −5,794 $48.62 $281,704
Aug 10, 2026 Rapport Therapeutics Inc. Open-market sale −14,171 $45.97 $651,441
Aug 10, 2026 Rapport Therapeutics Inc. Open-market sale −8,370 $46.75 $391,298
Jul 27, 2026 Rapport Therapeutics Inc. Open-market sale −2,203 $42.11 $92,768

Questions about Abraham Ceesay

What boards is Abraham Ceesay on?

Abraham Ceesay sits on the boards of Charles River Laboratories International Inc., Pacira BioSciences Inc. and Rapport Therapeutics Inc.

What company is Abraham Ceesay the CEO of?

Abraham Ceesay has been Chief Executive Officer of Rapport Therapeutics Inc. since June 2024.

How long has Abraham Ceesay served on boards?

Our records show at least 7 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.